EUVIMEDEUVIMED entdecken
Crossref

Endothelial Tgfbr2 Deficiency Ameliorate Liver Fibrosis Through Regulating Angiocrine Signalling and Macrophage Accumulation

Ru Huang, Juan Deng iD, Ke-Qi Wang, Chang-Peng Zhu, Chen-Hong Ding, Fei Chen, Xin Zhang iD, Wei-Fen Xie iD

Liver International · 2025-09 · 45 (9)

DOI: 10.1111/liv.70227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025-08. Verfasst von Ru Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Receptor, Transforming Growth Factor-beta Type II, Liver Cirrhosis, Macrophages, Endothelial Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Transforming growth factor (TGF)‐β signalling plays an indispensable role in promoting the activation of hepatic stellate cells and inducing epithelial‐mesenchymal transition of hepatocytes during liver fibrosis. Liver sinusoidal endothelial cells (LSECs) undergo capillarisation and promote inflammatory responses following liver injury. Here, we investigated the role of TGF‐β signalling in LSECs during liver fibrosis.

Methods

Single‐cell RNA‐sequencing (scRNA‐seq) datasets from healthy individuals and patients with cirrhosis were analysed to evaluate the expression of TGF‐β signalling related genes. Endothelial cell‐specific Tgfbr2 ‐knockout mice were generated and experimental liver fibrosis was induced by carbon tetrachloride injection or choline‐deficient high‐fat diet. Liver fibrosis was evaluated by qPCR, western blotting, histology and immunostaining. Primary LSECs were isolated and gene expression was analysed by RNA sequencing. Hepatic inflammation was assessed by qPCR, immunostaining and flow cytometry.

Results

ScRNA‐seq analysis based on GSE136103 showed TGFBR2 is elevated in LSECs from cirrhotic patients compared to healthy controls. LSEC‐specific Tgfbr2 depletion ameliorated injury‐induced LSEC capillarisation and endothelial‐to‐mesenchymal transition. RNA sequencing revealed that Tgfbr2 deficiency downregulated chemokine expression and reshaped angiocrine signalling in LSECs. Endothelial‐specific Tgfbr2 deletion inhibited pro‐inflammatory monocyte recruitment and attenuated hepatic inflammation during liver fibrosis. Furthermore, Tgfbr2 deletion in LSECs inhibited macrophage chemotaxis in vitro.

Conclusions

Endothelial TGF‐β signalling aggravates injury‐induced liver fibrosis by promoting LSECs capillarisation, EndMT and proinflammatory monocyte recruitment. These findings show the potential of targeting TGFBR2 in LSECs to control liver fibrotic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Transforming Growth Factor-beta Type IILiver CirrhosisMacrophagesEndothelial CellsAnimalsMiceMice, KnockoutHumansSignal TransductionMaleLiverCarbon TetrachlorideMice, Inbred C57BLTransforming Growth Factor betaDisease Models, AnimalEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

inflammationliver fibrosisliver sinusoidal endothelial cellmonocyte‐derived macrophagestransforming growth factor β receptor 2

Substanzen

Receptor, Transforming Growth Factor-beta Type IITgfbr2 protein, mouseTGFBR2 protein, humanCarbon TetrachlorideTransforming Growth Factor beta

Autor:innen und Institutionen

  • Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

ORCID-Profile: Juan Deng, Xin Zhang, Wei-Fen Xie

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, R., Deng, J., Wang, K. Q., Zhu, C. P., Ding, C. H., Chen, F., Zhang, X., & Xie, W. F. (2025). Endothelial Tgfbr2 Deficiency Ameliorate Liver Fibrosis Through Regulating Angiocrine Signalling and Macrophage Accumulation. Liver International, 45(9). https://doi.org/10.1111/liv.70227

Vancouver

Huang R, Deng J, Wang KQ, Zhu CP, Ding CH, Chen F, et al. Endothelial Tgfbr2 Deficiency Ameliorate Liver Fibrosis Through Regulating Angiocrine Signalling and Macrophage Accumulation. Liver International. 2025;45(9). doi:10.1111/liv.70227

BibTeX
@article{Huang2025,
  author = {Huang, Ru and Deng, Juan and Wang, Ke-Qi and Zhu, Chang-Peng and Ding, Chen-Hong and Chen, Fei and Zhang, Xin and Xie, Wei-Fen},
  title = {Endothelial Tgfbr2 Deficiency Ameliorate Liver Fibrosis Through Regulating Angiocrine Signalling and Macrophage Accumulation},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {9},
  doi = {10.1111/liv.70227}
}
Kostenlos starten →